Rescue Hearing Inc (RHI) was established to develop and monetize technology within the field of hearing loss. The company is built on a foundation of combining leading physician / researchers with the latest technologies in gene therapy. RHI’s initial product is a gene therapy (RHI100) which targets a genetic mutation known to cause deafness. RHI’S Scientific Advisory Board (SAB) are world renowned experts in hearing loss science as acknowledged by their peers. All SAB members share a passion for developing therapies and collaborate with scientists across the globe.